FDA Approves New Animal Drug for Topical Management of Dermatologic Disorders in Dogs and Cats

Summary

The US Food and Drug Administration (FDA) has approved an abbreviated new animal drug application (ANADA) for Med-Pharmex, Inc.'s nystatin, neomycin, thiostrepton, and triamcinolone acetonide ointment, which is intended for topical use in managing dermatologic disorders in canines and felines.